Delaware Group Equity Funds IV. Holdings as of Jun 30, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| UCB SA | 5.19% | $44.51M | 130,137 |
| ASTRAZENECA PLC | 3.27% | $32.50M | 131,243 |
| ABBVIE INCABBV | 4.19% | $31.46M | 125,000 |
| ELI LILLY & COMPANYLLY | 4.16% | $31.19M | 26,000 |
| REGENERON PHARMACEUTICALS INCREGN | 3.91% | $29.31M | 47,000 |
| UNITEDHEALTH GROUP INCUNH | 3.88% | $29.09M | 70,000 |
| PFIZER INCPFE | 3.84% | $28.78M | 1,195,000 |
| ROCHE HOLDING AGPreferred | 3.01% | $27.98M | 55,000 |
| MERCK & COMPANY INCMRK | 3.68% | $27.63M | 215,000 |
| GILEAD SCIENCES INCGILD | 3.54% | $26.53M | 210,000 |
| ELEVANCE HEALTH INCELV | 3.25% | $24.36M | 63,000 |
| VIATRIS INCVTRS | 2.48% | $18.58M | 1,170,018 |
| ORUKA THERAPEUTICS INCORKA | 2.41% | $18.08M | 190,000 |
| HALOZYME THERAPEUTICS INCHALO | 2.30% | $17.22M | 220,000 |
| AMGEN INCAMGN | 2.27% | $17.02M | 47,000 |
| ILLUMINA INCILMN | 2.11% | $15.82M | 90,000 |
| ALKERMES PLC | 1.82% | $13.62M | 260,000 |
| VIKING THERAPEUTICS INCVKTX | 1.72% | $12.88M | 330,100 |
| VERTEX PHARMACEUTICALS INCVRTX | 1.66% | $12.42M | 25,000 |
| ROIVANT SCIENCES LTD | 1.60% | $11.97M | 338,181 |
| NEUROCRINE BIOSCIENCES INCNBIX | 1.57% | $11.80M | 70,000 |
| SANOFI SA | 1.37% | $11.72M | 120,000 |
| ARCUS BIOSCIENCES INCRCUS | 1.56% | $11.69M | 379,100 |
| ZIMMER BIOMET HOLDINGS INCZBH | 1.42% | $10.68M | 124,000 |
| BOSTON SCIENTIFIC CORPBSX | 1.42% | $10.67M | 250,000 |
| UNIQURE NV | 1.34% | $10.02M | 217,500 |
| STRYKER CORPSYK | 1.26% | $9.45M | 30,000 |
| INCYTE CORPINCY | 1.21% | $9.07M | 80,000 |
| ALNYLAM PHARMACEUTICALS INCALNY | 1.20% | $9.03M | 30,000 |
| COGENT BIOSCIENCES INCCOGT | 1.19% | $8.90M | 230,000 |
| FEDERAL NATIONAL MORTGAGE ASSOCIATIONFNMA | 1.13% | $8.46M | 1,300,000 |
| MEDTRONIC PLC | 1.04% | $7.82M | 100,000 |
| CVS HEALTH CORPCVS | 1.03% | $7.76M | 75,000 |
| ABBOTT LABORATORIESABT | 0.97% | $7.26M | 80,000 |
| QUEST DIAGNOSTICS INCDGX | 0.85% | $6.36M | 30,000 |
| ANAPTYSBIO INCANAB | 0.84% | $6.33M | 93,732 |
| TARSUS PHARMACEUTICALS INCTARS | 0.84% | $6.29M | 100,000 |
| FEDERAL HOME LOAN MORTGAGE CORPFMCC | 0.84% | $6.28M | 1,050,000 |
| RIGEL PHARMACEUTICALS INCRIGL | 0.83% | $6.26M | 160,000 |
| BIOGEN INCBIIB | 0.81% | $6.05M | 28,000 |
| GRAIL INCGRAL | 0.77% | $5.80M | 85,000 |
| BIOMARIN PHARMACEUTICAL INCBMRN | 0.76% | $5.72M | 100,000 |
| VIR BIOTECHNOLOGY INCVIR | 0.68% | $5.10M | 500,000 |
| JOHNSON & JOHNSONJNJ | 0.68% | $5.08M | 20,000 |
| MONTE ROSA THERAPEUTICS INCGLUE | 0.65% | $4.84M | 200,000 |
| IMMUNOVANT INCIMVT | 0.63% | $4.70M | 122,100 |
| ABIVAX SAABVX | 0.53% | $4.00M | 30,000 |
| SYNDAX PHARMACEUTICALS INCSNDX | 0.52% | $3.93M | 180,000 |
| MADRIGAL PHARMACEUTICALS INCMDGL | 0.50% | $3.76M | 7,000 |
| GOLDMAN SACHS TRUSTCash or money market | 0.49% | $3.67M | 3,666,431 |